PolyPid Historical Cash Flow

PYPD Stock  USD 3.34  0.12  3.47%   
Analysis of PolyPid cash flow over time is an excellent tool to project PolyPid future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 1.9 M or Other Non Cash Items of 1.8 M as it is a great indicator of PolyPid ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining PolyPid latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether PolyPid is a good buy for the upcoming year.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.

About PolyPid Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in PolyPid balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which PolyPid's non-liquid assets can be easily converted into cash.

PolyPid Cash Flow Chart

At present, PolyPid's Total Cashflows From Investing Activities is projected to increase significantly based on the last few years of reporting. The current year's Depreciation is expected to grow to about 1.9 M, whereas Free Cash Flow is forecasted to decline to (18.3 M).

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by PolyPid to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of PolyPid operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from PolyPid's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into PolyPid current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.At present, PolyPid's Total Cashflows From Investing Activities is projected to increase significantly based on the last few years of reporting. The current year's Depreciation is expected to grow to about 1.9 M, whereas Free Cash Flow is forecasted to decline to (18.3 M).
 2023 2024 (projected)
Net Borrowings10.2M9.0M
Issuance Of Capital Stock8.7M16.9M

PolyPid cash flow statement Correlations

-0.12-0.78-0.230.70.90.050.27-0.580.710.790.18-0.050.08-0.080.340.36-0.53-0.73
-0.12-0.040.33-0.53-0.3-0.410.240.30.41-0.040.270.53-0.430.3-0.06-0.160.350.12
-0.78-0.04-0.05-0.72-0.75-0.01-0.740.67-0.8-0.88-0.49-0.35-0.03-0.08-0.43-0.150.130.69
-0.230.33-0.05-0.3-0.19-0.050.2-0.01-0.050.00.590.54-0.110.680.22-0.490.12-0.16
0.7-0.53-0.72-0.30.710.320.46-0.710.520.610.21-0.150.34-0.170.430.11-0.26-0.56
0.9-0.3-0.75-0.190.71-0.050.21-0.510.560.80.32-0.10.0-0.250.480.19-0.66-0.87
0.05-0.41-0.01-0.050.32-0.05-0.02-0.74-0.090.19-0.160.091.00.23-0.430.040.0-0.01
0.270.24-0.740.20.460.21-0.02-0.420.670.480.510.67-0.030.210.36-0.030.25-0.23
-0.580.30.67-0.01-0.71-0.51-0.74-0.42-0.44-0.75-0.21-0.28-0.76-0.20.03-0.130.150.52
0.710.41-0.8-0.050.520.56-0.090.67-0.440.620.510.34-0.080.060.45-0.02-0.14-0.56
0.79-0.04-0.880.00.610.80.190.48-0.750.620.330.390.230.020.130.29-0.25-0.75
0.180.27-0.490.590.210.32-0.160.51-0.210.510.330.43-0.180.370.74-0.73-0.16-0.68
-0.050.53-0.350.54-0.15-0.10.090.67-0.280.340.390.430.070.4-0.11-0.060.26-0.09
0.08-0.43-0.03-0.110.340.01.0-0.03-0.76-0.080.23-0.180.070.17-0.450.09-0.01-0.04
-0.080.3-0.080.68-0.17-0.250.230.21-0.20.060.020.370.40.170.04-0.250.35-0.03
0.34-0.06-0.430.220.430.48-0.430.360.030.450.130.74-0.11-0.450.04-0.52-0.37-0.6
0.36-0.16-0.15-0.490.110.190.04-0.03-0.13-0.020.29-0.73-0.060.09-0.25-0.520.010.25
-0.530.350.130.12-0.26-0.660.00.250.15-0.14-0.25-0.160.26-0.010.35-0.370.010.61
-0.730.120.69-0.16-0.56-0.87-0.01-0.230.52-0.56-0.75-0.68-0.09-0.04-0.03-0.60.250.61
Click cells to compare fundamentals

PolyPid Account Relationship Matchups

PolyPid cash flow statement Accounts

201920202021202220232024 (projected)
Change In Cash(3.3M)410K5.5M(1.3M)(3.5M)(3.3M)
Free Cash Flow(18.2M)(22.8M)(35.4M)(36.1M)(17.4M)(18.3M)
Change In Working Capital(1.0M)(1.7M)4.3M(1.1M)(110K)(104.5K)
Begin Period Cash Flow7.8M4.5M4.9M10.5M9.1M5.5M
Total Cashflows From Investing Activities(23.6M)(40.8M)36.9M16.6M19.1M20.0M
Other Cashflows From Financing Activities(23.6M)17K1.0M696K3.9M2.9M
Depreciation947K1.0M1.1M1.7M1.8M1.9M
Other Non Cash Items(11.4M)11.4M4.6M289K1.7M1.8M
Capital Expenditures879K1.2M3.0M1.8M196K186.2K
Total Cash From Operating Activities(17.4M)(21.6M)(32.4M)(34.3M)(17.2M)(18.1M)
Net Income(6.9M)(36.9M)(42.6M)(39.6M)(23.9M)(25.1M)
Total Cash From Financing Activities37.7M62.8M1.0M16.4M10.0M19.0M
End Period Cash Flow4.5M4.9M10.5M9.1M5.7M5.8M
Stock Based Compensation976K4.6M4.8M4.3M3.4M2.6M
Investments(23.6M)(40.8M)39.9M16.6M3.8M4.0M
Change To Operating Activities(1.5M)835K2.1M(530K)(609.5K)(579.0K)
Change To Netincome(10.4M)16.0M4.8M4.6M4.1M4.0M
Change To Liabilities449K(607K)2.2M(547K)(629.1K)(597.6K)
Change To Account Receivables306K69K(1.9M)123K110.7K116.2K
Issuance Of Capital Stock37.6M62.8M3.8M4.4M8.7M16.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PolyPid. If investors know PolyPid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PolyPid listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(7.22)
Return On Assets
(0.65)
Return On Equity
(4.97)
The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PolyPid's value and its price as these two are different measures arrived at by different means. Investors typically determine if PolyPid is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PolyPid's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.